Glucodichotomine BCAS# 845673-16-7 |
2D Structure
Quality Control & MSDS
Package In Stock
Number of papers citing our products
Cas No. | 845673-16-7 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C20H22N2O9 | M.Wt | 434.4 |
Type of Compound | Indoles | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Glucodichotomine B Dilution Calculator
Glucodichotomine B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.302 mL | 11.5101 mL | 23.0203 mL | 46.0405 mL | 57.5506 mL |
5 mM | 0.4604 mL | 2.302 mL | 4.6041 mL | 9.2081 mL | 11.5101 mL |
10 mM | 0.2302 mL | 1.151 mL | 2.302 mL | 4.6041 mL | 5.7551 mL |
50 mM | 0.046 mL | 0.2302 mL | 0.4604 mL | 0.9208 mL | 1.151 mL |
100 mM | 0.023 mL | 0.1151 mL | 0.2302 mL | 0.4604 mL | 0.5755 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Podecdysone C
Catalog No.:BCX1661
CAS No.:19458-46-9
- lagunamine
Catalog No.:BCX1660
CAS No.:126721-42-4
- (E)-Isoconiferin (Citrusin D)
Catalog No.:BCX1659
CAS No.:113349-27-2
- 1,2,3,7-Tetrahydroxy-8-methoxy-6-methyl-9,10-anthracenedione
Catalog No.:BCX1658
CAS No.:130018-57-4
- 2,2-Diphenyl-1-picrylhydrazyl radical(DPPH)
Catalog No.:BCX1657
CAS No.:1898-66-4
- 4-Isopropyl-6-methyl-1-tetralone
Catalog No.:BCX1656
CAS No.:1270089-06-9
- (-)-(E)-a-Atlantone
Catalog No.:BCX1655
CAS No.:108645-54-1
- Tetrahydrojatrorrhizine
Catalog No.:BCX1654
CAS No.:27313-86-6
- Entadamide A 2' -O- ( 6''-O-β-D-glucopyranosyl ) -β-D-glucopyranoside
Catalog No.:BCX1653
CAS No.:1427191-48-7
- Erythrosin B
Catalog No.:BCX1652
CAS No.:568-63-8
- β-D-glucopyranosyl 3-O-[(O-β-D-xylopyranosyl-(1→2) (O-α-L-rhamnopyranosyl(1→3)β-D-glucuronopyranosyl...
Catalog No.:BCX1651
CAS No.:111567-21-6
- 1-Methyl-2-[(6Z,9Z)-6,9-pentadecadiene]-4(1H)-quinolone
Catalog No.:BCX1650
CAS No.:120693-52-9
- Rubrofusarin-6-O-β-D-glucopyranoside
Catalog No.:BCX1663
CAS No.:132922-80-6
- (1E)-3-Methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one
Catalog No.:BCX1664
CAS No.:383368-26-1
- (-)-10-epi-α-Cyperone
Catalog No.:BCX1665
CAS No.:2303-31-3
- Inonotusol F
Catalog No.:BCX1666
CAS No.:1534433-74-3
- Copteroside G
Catalog No.:BCX1667
CAS No.:86438-31-5
- Uvariol
Catalog No.:BCX1668
CAS No.:56362-97-1
- Odoratisol B
Catalog No.:BCX1669
CAS No.:891182-94-8
- 19-epi-Scholaricine
Catalog No.:BCX1670
CAS No.:132923-06-9
- Anhuienoside B
Catalog No.:BCX1671
CAS No.:1233510-75-2
- Garcinielliptone HD
Catalog No.:BCX1672
CAS No.:1008376-90-6
- Lupulone C
Catalog No.:BCX1673
CAS No.:613683-50-4
- Cararosinol A
Catalog No.:BCX1674
CAS No.:651733-57-2
Two-dimensional chromatography based on on-line HPLC-DPPH bioactivity-guided assay for the preparative isolation of analogue antioxidant compound from Arenaria kansuensis.[Pubmed:28152453]
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 1;1046:81-86.
Traditional Tibetan medicine is important for discovery of drug precursors. However, information about the chemical composition of traditional Tibetan medicine is very limited due to the lack of appropriate chromatographic purification methods. In the present work, A. kansuensis was taken as an example and a novel two-dimensional reversed-phase/hydrophilic interaction liquid chromatography(HILIC) method based on on-line HPLC-DPPH bioactivity-guided assay was developed for the purification of analogue antioxidant compounds with high purity from the extract of A. kansuensis. Based on the separation results of many different chromatographic stationary phases, the first-dimensional (1D) preparation was carried on a RP-C18HCE prep column, and 2 antioxidant fractions were obtained from the 800mg crude sample with a recovery of 56.7%. A HILIC-XAmide prep column was selected for the second-dimensional (2D) preparation. Finally, a novel antioxidant beta-carboline Alkaloids (Glusodichotomine AK) and 4 known compounds (Tricin, Homoeriodictyol, Luteolin, Glucodichotomine B) were purified from A. kansuensis. The purity of the compounds isolated from the crude extract was >98%, which indicated that the method built in this work was efficient to manufacture single analogue antioxidant compounds of high purity from the extract of A. kansuensis. Additionally, this method showed great potential in the preparation of analogue structure antioxidant compounds and can serve as a good example for the purification of analogue structure antioxidant carboline alkaloids and flavonoids from other plant materials.
Bioactive constituents from Chinese natural medicines. XIV. New glycosides of beta-carboline-type alkaloid, neolignan, and phenylpropanoid from Stellaria dichotoma L. var. lanceolata and their antiallergic activities.[Pubmed:15467234]
Chem Pharm Bull (Tokyo). 2004 Oct;52(10):1194-9.
A new beta-carboline-type alkaloidal glycoside, Glucodichotomine B, four new neolignan glycosides, dichotomosides A, B, C, and D, and a new phenylpropanoid glycoside, dichotomoside E, were isolated from a Chinese natural medicine, the roots of Stellaria dichotoma L. var. lanceolata. The structures of the new glycosides were determined on the basis of chemical and physicochemical evidence. Among them, dichotomoside D inhibited the release of beta-hexosaminidase (IC(50)=64 microM) as well as tumor necrosis factor-alpha and interleukin-4 (IC(50)=16, 34 microM) in RBL-2H3 cells. These findings suggest that dichotomoside D is more effective against the late-phase reactions in type I allergy than in the immediate phase.